Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glucim V 1mg/500mg/0.2mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Camrut Pharma

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Glucim V 1mg/500mg/0.2mg Tablet SR

DiabetaComb 1mg/500mg/0.2mg Extended-Release Tablets are classified as antidiabetic medications. This combination therapy is indicated for managing type 2 diabetes in adults, effectively regulating blood glucose. DiabetaComb should be administered with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood glucose monitoring. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to hyperglycemia, increasing the risk of complications including nephropathy, retinopathy, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan, incorporating a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are essential for prevention. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, edema, visual disturbances, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before initiating treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (complete blood count and liver function tests) are recommended.

Uses of Glucim V 1mg/500mg/0.2mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glucim V 1mg/500mg/0.2mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The Glucim V 1mg/500mg/0.2mg Tablet SR should be swallowed whole and not chewed, crushed, or broken. Administer this medication on an empty stomach.

Common Side effects of Glucim V 1mg/500mg/0.2mg Tablet SR:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Glucim V 1mg/500mg/0.2mg Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the Glucim V 1mg/500mg/0.2mg Tablet SR whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.

How Glucim V 1mg/500mg/0.2mg Tablet SR works:

Glucim V SR tablets (1mg/500mg/0.2mg) contain a triple-action antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glucim V 1mg/500mg/0.2mg SR tablets with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Glucim V 1mg/500mg/0.2mg tablet may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any hazards prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Prolonged-release Glucim V tablets (1mg/500mg/0.2mg) are likely not safe for breastfeeding mothers. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyUNSAFE

The use of Glucim V 1mg/500mg/0.2mg SR tablets is inadvisable for individuals with impaired kidney function and should be forgone. Medical advice is necessary. Furthermore, this medication is contraindicated in patients exhibiting severe renal insufficiency.

LiverLiverCAUTION

Patients with liver impairment should use Glucim V 1mg/500mg/0.2mg Tablet SR cautiously, potentially requiring dosage modification. Consult a physician. For those with mild to moderate liver disease, initiation should be at a reduced dosage; the medication is contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Glucim V 1mg/500mg/0.2mg Tablet SR :

Should you forget to take a Glucim V 1mg/500mg/0.2mg Tablet SR, administer it immediately upon remembering. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take more than the prescribed dose.

Facts to Know About Glucim V 1mg/500mg/0.2mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glucim V 1mg/500mg/0.2mg Tablet SR

Glucim V SR tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release, metformin reduces liver glucose production and enhances insulin sensitivity, while voglibose, an alpha-glucosidase inhibitor, lowers post-meal glucose levels. This medication is not suitable for type 1 diabetes.
Glucim V 1mg/500mg/0.2mg SR tablets may cause common side effects including low blood sugar (hypoglycemia), nausea, diarrhea, altered taste, gas, stomach pain, headache, rash, and respiratory infections.
Glucim V 1mg/500mg/0.2mg Tablet SR is contraindicated in patients allergic to its components or excipients, those with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, and underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Glucim V 1mg/500mg/0.2mg SR tablets with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glucim V 1mg/500mg/0.2mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and ensure it's kept out of reach of children, pets, and others.
Glucim V 1mg/500mg/0.2mg ...
156
MRP 180
13% off